Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

The official journal of Orphanet, the portal for rare diseases and orphan drugs.

Rare Disease Day 2025

Since 2008, the last day of February has been dedicated to raising awareness about rare diseases. This global campaign is a precious opportunity for everyone to contribute to raising attention to 300 million rare disease patients and support initiatives around the world aiming to improve their lives.

To mark this day, Orphanet Journal of Rare Diseases will also highlight relevant content on the journal’s homepage, featuring our newly published blog posts and Editorials.

Find more insightful blog posts related to Rare Disease Day on the Springer Nature Research Communities website, and in the summary blog here.

Patient involvement in clinical trials: a paradigm shift in research

New Editorial by Editor-in-Chief, Francesc Palau, and Managing Editor Jordi Pijuan, highlights the critical role of clinical trials in advancing treatments for rare diseases. Patient involvement is essential for understanding unique health challenges and developing effective therapies. Read full article here.

The voice of patients and families in clinical research: towards more inclusive research for rare diseases

New blog by Jordi Pijuan, Managing editor OJRD, Sant Joan de Déu Research Institute and CIBER of Rare Diseases

“As Rare Disease Day 2025 approaches, it is imperative to reaffirm our commitment to promoting inclusive, ethical, and patient-centered research methodologies. Effective collaboration among all stakeholders (patients, researchers, and clinicians) is crucial for the development of transformative solutions that address the complex needs of individuals living with rare diseases."

Call for Papers: Current Updates in Adult Inherited Metabolic Disorders

Orphanet Journal of Rare Diseases is calling for submissions to our Collection on Current Updates in Adult Inherited Metabolic Disorders. This Collection aims to provide a comprehensive update on the current state of adult inherited metabolic disorders, fostering a deeper understanding and encouraging further research in this evolving field.

Finding Our Voices: Amplification and Quality of Life in Women with Turner Syndrome

We are delighted to present behind paper story shared by Dr. Mann and Dr. VanLooy:

”As we approach Rare Disease Day 2025, I urge you to join me in raising awareness about Turner syndrome and other rare conditions. Let us work together to amplify the voices of those with rare diseases and ensure that they have access to the care and support they need to thrive.’ Read full blog here.

A European Rare Neuromuscular Diseases Registry Hub

Antonio Atalaia shares Behind the Paper blog post on research Communities.  

Rare diseases are characterised by a shortage of patients and expertise. Providing the best care requires shared cross-border expertise and data exchange. A registry hub is best for bridging siloed patient information resources for rare neuromuscular diseases.

Read full blog here.

A therapeutic approach to pantothenate kinase associated neurodegeneration

by José Antonio Sánchez Alcázar, Professor, Pablo de Olavide University

This behind paper  blog discusses the therapeutic effects of multitarget complex supplements in the rare genetic neurological disorder pantothenate-kinase-associated neurodegeneration (PKAN) which causes neurodegeneration with brain iron accumulation.

The Student Voice Prize 2024

The Student Voice Prize is an annual, international essay competition that raises the profile of rare diseases within the medical field, particularly with medical students, nurses and scientists who may have never come across rare diseases in their training.

Beacon and Medics4RareDiseases host the competition together and the winning essay is published in The Orphanet Journal of Rare Diseases.

Congratulations to the authors of the winning and runner-up essays. We are excited to highlight this content for the occasion of Rare Disease Day 2025.

The overall winning essay of the Student Voice Prize 2024

New Content ItemHelping the medicine go down: the role of the healthcare professional in a young person’s experience of achalasia, a rare oesophageal motility disorder. 

by Geena Capps, University of Oxford, Oxford, UK. 

This remarkable essay highlights the critical role that individual healthcare professionals play in shaping young patients' experiences of their condition. Read full article here


Read these insightful runners-up essays, featured in blog format on Springer Nature’s Research Communities website:

I can hear you”: How Illness Perceptions Shape the Identity of Children with Rare Diseases 

by Lois Williams, Medical Student, University College London (UCL)
In her essay, Lois explores the lasting implications of illness perceptions, after the elusive diagnosis is found.

Addressing the Research Divide

by Katie Whitcher, Medical Student, University of Bristol
Read this interesting blog, to find out challenges of conducting research in rare disease populations.

Congratulations also to Sindhu Khanna, for her essay Listening to the unheard, youth voices in rare disease policy, illustrating the obstacles young people with rare diseases face and emphasizing the urgent need for youth-inclusive policies. This essay was selected winner in English as a second language category.

Editor-in-Chief
Francesc Palau, MD, PhD, Hospital Sant Joan de Déu Barcelona and CIBERER, Spain 
Deputy Editor-in-Chief
Brett J. Bordini, MD, Medical College of Wisconsin, USA

Aims and scope

Orphanet Journal of Rare Diseases is an open access, peer-reviewed journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high-quality reviews on specific rare diseases. In addition, the journal may consider articles on clinical trial outcome reports, either positive or negative, and articles on public health issues in the field of rare diseases and orphan drugs. The journal does not accept case reports which do not present clinical or pathological findings that can provide information about the mechanisms of a disease. Case reports which just present phenotype information, should not be considered.

About Orphanet



Orphanet is a unique resource, gathering and improving knowledge on rare diseases so as to improve the diagnosis, care and treatment of patients with rare diseases. Orphanet aims to provide high-quality information on rare diseases, and ensure equal access to knowledge for all stakeholders. Orphanet also maintains the Orphanet rare disease nomenclature (ORPHAcode), essential in improving the visibility of rare diseases in health and research information systems.
Orphanet makes available: 

Articles

  1. Authors: Cecilie Fremstad Rustad, Ragnheidur Bragadottir, Kristian Tveten, Hilde Nordgarden, Jeanette Ullmann Miller, Pamela Marika Åsten, Gisela Vasconcelos, Mari Ann Kulseth, Øystein Lunde Holla, Hanne Gro Olsen, Charlotte von der Lippe and Solrun Sigurdardottir

  1. Authors: Nicole R Tartaglia, Susan Howell, Ashley Sutherland, Rebecca Wilson and Lennie Wilson

  2. Authors: Renzo Galanello and Raffaella Origa

2022

Thematic series
MedTech Innovation & Rare Diseases


2015

Review series
Living with a rare disease
Collection published: 18 February 2015


2014

Thematic series
Rare Disease Day 2014
Collection published: 28 February 2014


2013

Cross journal collection
Rare Diseases Day 2013
Collection published: 28 February 2013

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Featured series: Diagnosis of rare diseases – strategies and structures

We are pleased to announce a new thematic series, edited by Francesc Palau (Hospital Sant Joan de Déu Barcelona and CIBERER, Spain) and Holm Graeßner (University Hospital Tübingen, Germany). This new series will explore the strategies and solutions which have been developed, tested, validated and/or deployed, in order to improve diagnosis of rare disease patients. You can find more information about the scope of the series here.

Featured series: Medical technologies for rare diseases

New Content ItemWe are pleased to announce a new thematic series, guest edited by Anneliene Jonker (University of Twente, The Netherlands) and Marc Dooms (University Hospitals Leuven, Belgium).

Orphan devices constitute a very diverse group of products, reflecting the broad field of rare disease. Many orphan devices provide essential functions for patients with rare diseases, their carers, and the healthcare professionals using them. Nevertheless, there are very few medical devices that are specifically developed for rare diseases, while many patients and carers express a substantial unmet need for new medical devices for their conditions. This new series will explore the questions which need to be answered, in order to raise the profile of this field, helping current and future rare disease patients worldwide. Find out more about the scope here.

Featured series: Undiagnosed rare diseases

New Content ItemOur new thematic series, guest edited by David Adams, delves into the challenges and opportunities which exist for patients living with undiagnosed rare diseases. We are looking to publish material which speaks to the importance of a diagnosis, of utilizing individual approaches in treating patients, of functional studies, and the best ways to share information. For more information about the series (including submission info), please click here.

Cushing’s Hub Webinar Series 2023 – Registration Now Open!

The Cushing’s Hub Editorial Board is delighted to announce the second event in the Cushing’s Hub Webinar Series – Explore Real-World Clinical Scenarios in Mild Autonomous Cortisol Secretion (MACS) on Tuesday 24 October at 16.00–17.00 Central European Time.

Chaired by Dr Susan M. Webb, Barcelona, Spain, watch panellists Assoc. Prof. Iacopo Chiodini, Milan, Italy, and Dr Irina Bancos, Rochester, MN, USA discuss, using practical case examples, the challenges surrounding the clinical management of low-grade excessive cortisol secretion and take questions from the audience.

An application has been made to the UEMS EACCME® for CME accreditation of this event.

Click here to register.

PNDS Recommendations

New Content ItemWe are proud to present the first of a series of recommendations from the PNDS on rare Autoimmune and Autoinflammatory Disease. This first set is about the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides). Read more here!

FOP

In collaboration with Dr. Robert Pignolo and an international faculty of experts, Springer healthcare IME has developed an independent educational program entitled, FOP: Recognition, Treatment and Hope. Highlighting a rare disease that is too often under-diagnosed or misdiagnosed, this free-to-access program aims to raise awareness and highlight the advances being made which have the potential to change the outlook for people with fibrodysplasia ossificans progressiva (FOP). Two resources are CME-accredited, an interactive case-based webcast and eLearning modules, both of which cover important topics within the diagnosis and management of FOP. Also included is the opportunity to test your knowledge through an image-based clinical diagnosis quiz, submit a case to our panel of experts for review, keep up-to-date on the latest news and find the FOP specialist center nearest to your location.

Announcing the launch of In Review

Orphanet Journal of Rare Diseases, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

See what the Orphanet Journal of Rare Diseases In Review platform looks like

Affiliated with

  • Orphanet Journal of Rare Diseases is the official journal of Orphanet, the portal for rare diseases and orphan drugs.

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.4
    5-year Journal Impact Factor: 3.9
    Source Normalized Impact per Paper (SNIP): 1.464
    SCImago Journal Rank (SJR): 1.182

    Speed 2024
    Submission to first editorial decision (median days): 34
    Submission to acceptance (median days): 200

    Usage 2024
    Downloads: 4,588,277
    Altmetric mentions: 2,033